Yumeng Li

机构：Capital University, Sun Yat-sen University, Capital Medical University, Sun Yat-sen University Cancer Center, UC Davis Comprehensive Cancer Center, Harbin Veterinary Research Institute, University of California, Davis · ORCID：0000-0002-1921-3888

发表论文 13 篇 · 总被引 45 次 · h-index 3

代表论文

Multifunctional and Scalable Nanoparticles for Bimodal Image-Guided Phototherapy in Bladder Cancer Treatment (2025 · Nano-Micro Letters · 被引 19)
Preoperative Three-Dimensional Morphological Tumor Features Predict Microvascular Invasion in Hepatocellular Carcinoma (2023 · Academic Radiology · 被引 9)
Pemetrexed for previously treated patients with metastatic gastric cancer: a prospective phase II study (2014 · British Journal of Cancer · 被引 8)
MARCH2 inhibits avian leukosis virus replication by targeting gp85 for ubiquitination and degradation (2025 · Journal of Virology · 被引 3)
Meta‐analysis evaluating the efficacy and safety of various Bruton tyrosine kinase (BTK) inhibitors for central nervous system lymphoma: Novel covalent BTK inhibitors, except for ibrutinib, also demonstrate good efficacy in the treatment of primary central nervous system lymphoma (2025 · Cancer · 被引 3)
[On detection of chromogranin A, synaptophysin, neuronspecific enolase and progastrin-releasing peptide in small cell lung cancer]. (2022 · PubMed · 被引 2)